Side-by-side comparison of AI visibility scores, market position, and capabilities
Micromobility operator with shared e-scooters and bikes in 200+ cities; $1B+ raised from Alphabet and Uber with ~$750M annual revenue and EBITDA profitability after Bird's 2023 bankruptcy exit.
Lime is a micromobility company operating shared electric scooters and bikes in 200+ cities across five continents — providing app-based short-trip urban transportation for commuters, tourists, and city dwellers through a pay-per-ride or subscription model that cities have adopted as part of their sustainable transportation infrastructure. Founded in 2017 in San Mateo, California as LimeBike, Lime raised over $1 billion in total funding from Alphabet (Google Ventures), Uber, Bain Capital Ventures, and Andreessen Horowitz, generating approximately $750 million in annual revenue and achieving EBITDA profitability in key markets.
Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.
AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.